Consolidated Balance Sheets - USD ($) $ in Thousands		Jun. 30, 2024	Jun. 30, 2023
Current assets:
Cash and cash equivalents		$ 68,570	$ 89,402
Restricted cash		485	524
Accounts receivable, net of allowance for credit losses of $2,251 and $3,079 as of June 30, 2024 and June 30, 2023, respectively	[1]	92,001	74,777
Inventories		138,324	145,150
Prepaid expenses and other current assets	[2]	23,006	27,612
Deferred cost of revenue		850	568
Total current assets		323,236	338,033
Property and equipment, net		24,774	20,926
Investment in joint venture		9,826	15,128
Operating lease right-of-use assets, net		33,773	25,853
Goodwill		57,672	57,681
Intangible assets, net		59	210
Restricted cash		1,337	1,276
Other assets		17,950	20,107
Total assets		468,627	479,214
Current liabilities:
Accounts payable		50,020	33,739
Accrued compensation		17,128	23,793
Operating lease liabilities		6,218	4,151
Other accrued liabilities		28,508	38,271
Customer advances		13,988	20,777
Deferred revenue		71,649	72,185
Short-term debt, net of unamortized debt costs		7,756	5,721
Total current liabilities		195,267	198,637
Long-term liabilities:
Operating lease liabilities		32,373	23,602
Long-term other liabilities		7,389	4,675
Deferred revenue		24,114	27,079
Long-term debt, net of unamortized debt costs		164,400	171,562
Total liabilities		423,543	425,555
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, $0.001 par value; authorized: 5,000,000 shares; no shares issued and outstanding			0
Common stock, $0.001 par value; authorized: 200,000,000 shares as of June 30, 2024 and June 30, 2023, respectively; issued and outstanding: 100,194,932 and 96,534,609 shares at June 30, 2024 and June 30, 2023, respectively		100	97
Additional paid-in-capital		566,887	555,276
Accumulated other comprehensive income (loss)		(4,222)	422
Accumulated deficit		(517,681)	(502,136)
Total stockholders' equity		45,084	53,659
Total liabilities and stockholders’ equity		$ 468,627	$ 479,214

[1] Included accounts receivable from the joint venture, an equity method investment, of $25,339 and $10,304 at June 30, 2024, and June 30, 2023, respectively. See Note 11.

[2] Included other receivable from the joint venture, an equity method investment, of $743 and $100 at June 30, 2024, and June 30, 2023, respectively.